22 Dez 2025 | Press release
We are pleased to share that last Friday marked an important milestone for Technophage with the End of Study of the TP-102 Phase 2b clinical trial. We would like to sincerely thank our CRO partners, Principal Investigators, and hospital teams in the United States and...
10 Jul 2025 | Sem categoria
Technophage S.A., a clinical-stage biopharmaceutical company focused on developing innovative therapies for areas of unmet medical need, today announces the initiation of a Phase 1b/2a clinical trial to evaluate TZ-161 for the treatment of acute spinal cord...
